{"id":"W4400741621","doi":"10.1080/13696998.2024.2379212","title":"Modelling the opportunity for cost-savings or patient access with biosimilar adalimumab and tocilizumab: a European perspective","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Fresenius Kabi","keywords":"Biosimilar; Medicine; Tocilizumab; Adalimumab; Intensive care medicine; Rheumatoid arthritis; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002531611,0.00128032,0.0009833131,0.001027671,0.0003352047,0.002678073,0.001436309,0.003187695,0.01020342],"category_scores_gemma":[0.007647919,0.0007626016,0.002749569,0.001265208,0.0007131059,0.002025274,0.00109068,0.00167362,0.0005167471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003451288,"about_ca_system_score_gemma":0.001700602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02444433,"about_ca_topic_score_gemma":0.01021412,"domain_scores_codex":[0.9986701,0.0008300076,0.0000394955,0.0001763476,0.00007177197,0.0002122969],"domain_scores_gemma":[0.9949824,0.004035681,0.0004706855,0.0001238209,0.0002091054,0.0001783763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0005265108,0.0001657013,0.003277467,0.0001516497,0.0001733145,0.0001693215,0.00006888756,0.9785997,0.0003351402,0.01152394,0.0006677069,0.004340485],"study_design_scores_gemma":[0.0004598133,0.0004922322,0.003035884,0.0001409761,0.0003894551,0.0001712995,0.0002308437,0.9754667,0.0004538188,0.01455181,0.004549505,0.00005762821],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.902322,0.005079153,0.04290564,0.003426461,0.0001193752,0.0003266241,0.004698063,0.00009599305,0.04102662],"genre_scores_gemma":[0.9842317,0.001038124,0.006896841,0.0002265552,0.00002739328,0.0001506472,0.00070554,0.00002681481,0.006696417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02444433,"threshold_uncertainty_score":0.04860413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08273379655443044,"score_gpt":0.3413688276508669,"score_spread":0.2586350310964365,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}